Search
IVTEAM

Webinar examines vascular access challenges due to the Covid 19 pandemic

"The first webinar on 13th January you will be able to hear Maya Guerrero and Prof Heather Loveday describing vascular access challenges surrounding Covid 19, linking evidence to practice" IPS IV Special Interest Group Webinar (2021).

"The first webinar on 13th January you will be able to hear Maya Guerrero and Prof Heather Loveday describing vascular access challenges surrounding Covid 19, linking evidence to practice" IPS IV Special Interest Group Webinar (2021).

ReTweet

The IV Forum are pleased to announce a series of Webinars for 2021 and would like you to hold the first three dates in your diaries; January 13th, February 11th and March 16th all at 4.30pm to 6pm. The first webinar on 13th January you will be able to hear Maya Guerrero and Prof Heather Loveday describing vascular access challenges surrounding Covid 19, linking evidence to practice.

This webinar is kindly sponsored by Vygon.

When: Jan 13, 2021 04:30 PM London

Topic: IPS IV Special Interest Group Webinar

Passcode to join the webinar: 178325

join Webinar
Facebook Twitter Linkedin Rss Envelope

About IVTEAM citation library

IVTEAM has established itself as a core global resource for infusion and vascular access practitioners. Each day 6K users have access thousands of pages of easy to access relevant intravenous news and updates. IVTEAM offers its visitors a premier service that has no financial or subscriber based restrictions. The editorial stance of IVTEAM is to ensure no editorial restrictions exist; content remains unbiased and independent.

It is crucial that IVTEAM stays up-to-date and offers visitors regular, current updates. Each day news feeds are analysed, websites searched and various additional sources of information visited. This results in large amounts of data being sifted through for relevant information every day. Only a small amount of data is relevant to IV practice and makes it onto IVTEAM.

Read more
Copyright 2024 © IVTEAM. All rights Reserved.